Seeing Is Believing
Healthcare - Sector
Iteos Therapeutics's activity chart (see below) currently has 63 price targets and 47 ratings on display.
Analysts average stock forecasts to be materialized ratio is 11.66% with an average time for these price targets to be met of 103.5 days.
Most recent stock forecast was given by from WELLS FARGO on 07-Aug-2025. First documented stock forecast 18-Aug-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Aug-2025
$11
$0.85 (8.37%)
$12
1 years 2 months ago
(07-Aug-2025)
0/6 (0%)
$0.87 (8.59%)
Hold Since 22-Jul-2025
$10
$-0.15 (-1.48%)
1 years 2 months 15 days ago
(22-Jul-2025)
0/3 (0%)
$-0.12 (-1.19%)
Buy Since 18-Aug-2020
$12
$1.85 (18.23%)
1 years 4 months 9 days ago
(28-May-2025)
1/6 (16.67%)
$1.94 (19.28%)
490
Buy Since 05-May-2021
$21
1 years 4 months 23 days ago
(14-May-2025)
1/11 (9.09%)
$13.9 (195.77%)
198
Buy Since 16-Mar-2023
$8
$-2.15 (-21.18%)
$29
1 years 4 months 24 days ago
(13-May-2025)
1/3 (33.33%)
$0.15 (1.91%)
6
What is ITOS (Iteos Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ITOS (Iteos Therapeutics)?
Which analyst has the most public recommendations on ITOS (Iteos Therapeutics)?
Which analyst is the currently most bullish on ITOS (Iteos Therapeutics)?
Which analyst is the currently most reserved on ITOS (Iteos Therapeutics)?